• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconMartin Shkreli

Martin Shkreli

0
Martin Shkreli, former chief executive officer of Turing Pharmaceuticals and KaloBios Pharmaceuticals Inc, departs after a hearing at U.S. Federal Court in Brooklyn, New York
HealthMartin Shkreli May Spend 20 Years in Prison
By Chris MorrisFebruary 27, 2018
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
HealthMartin Shkreli’s Lawyer Will Probably Join Him in Prison
By David Z. MorrisDecember 27, 2017
Jury Deliberations Continue In Martin Shkreli Securities Fraud Trial
LeadershipProsecutors Want Martin Shkreli to Forfeit His Wu Tang Clan CD
By ReutersDecember 1, 2017
Former Turing Pharmaceuticals CEO Martin Shkreli Case Nears End As Lawyers Prepare For Final Argument
TechA New ICO Wants to Get That Wu-Tang Album Out of Martin Shkreli’s Hands
By David Z. MorrisSeptember 25, 2017
Ex-pharmaceutical executive Martin Shkreli exits the U.S. District Court for the Eastern District of New York in Brooklyn.
Leadership4 Reasons Why People Hate Martin Shkreli So Much
By Aric JenkinsSeptember 14, 2017
Jury Deliberations Continue In Martin Shkreli Securities Fraud Trial
Tech‘Pharma Bro’ Martin Shkreli Heads to Jail For Placing Bounty on Hillary Clinton’s Hair
By ReutersSeptember 13, 2017
Former Turing Pharmaceuticals CEO Martin Shkreli Jury To Start Deliberations In Fraud Trial
HealthMartin Shkreli Is Really Sorry for Offering People $5,000 to Steal Hillary Clinton’s Hair
By Sy MukherjeeSeptember 12, 2017
Former Turing Pharmaceuticals CEO Martin Shkreli On Trial For Securities Fraud
LeadershipProsecutors Want Martin Shkreli Jailed After Hillary Clinton Hair ‘Threat’
By Lucinda ShenSeptember 8, 2017
<> on August 4, 2017 in New York City.
Arts & EntertainmentMartin Shkreli Is Holding His Wu-Tang Album Hostage on eBay
By Emily PriceSeptember 6, 2017
Why Martin Shkreli Won’t Be the Last Pharma Bro
CommentaryWhy Martin Shkreli Won’t Be the Last Pharma Bro
By Josh HoxieAugust 8, 2017
Former Turing Pharmaceuticals CEO Martin Shkreli On Trial For Securities Fraud
FinanceWhy Martin Shkreli Is Guilty When Investors Didn’t Lose
By BloombergAugust 5, 2017
Former Turing Pharmaceuticals CEO Martin Shkreli Jury To Start Deliberations In Fraud Trial
FinanceMartin Shkreli: Why the ‘Most-Hated’ CEO Is Strutting to Jail
By BloombergAugust 5, 2017
Martin Shkreli, former chief executive officer for Turing Pharmaceuticals AG.
HealthNewly Convicted ‘Pharma Bro’ Martin Shkreli Shined a Light on Pharma’s Biggest Scandals
By Sy MukherjeeAugust 4, 2017
Former Turing Pharmaceuticals CEO Martin Shkreli Case Nears End As Lawyers Prepare For Final Argument
FinanceJury to Soon Begin Deliberations in ‘Pharma Bro’ Martin Shkreli’s Fraud Trial
By ReutersJuly 28, 2017
House Oversight Hearing On Prescription Drug Price Increases
LeadershipLetter from Martin Shkreli: “I Hope To See You and Your Four Children Homeless”
By Chris MorrisJuly 19, 2017
0
Most Popular
Success
Two-thirds of parents say their adult Gen Z kids still rely on them financially  for support—even though it's putting them under strainplaceholder alt text
By Fortune EditorsMarch 31, 2026
Economy
Jerome Powell says the $39 trillion national debt is ‘not unsustainable,’ but warns the trajectory ‘will not end well’placeholder alt text
By Fortune EditorsMarch 30, 2026
Personal Finance
Current price of gold as of April 1, 2026placeholder alt text
By Fortune EditorsApril 1, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.